Avalo Therapeutics Inc. (AVTX) Debt to Equity Ratio
Avalo Therapeutics Inc. (AVTX) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2015-12-31 | 0.66 |
| 2016-12-31 | 26.87 |
| 2017-12-31 | 0.54 |
| 2018-12-31 | 2.36 |
| 2019-12-31 | 0.72 |
| 2020-12-31 | 0.78 |
| 2021-12-31 | 2.48 |
| 2022-12-31 | -4.06 |
| 2023-12-31 | 1.87 |
| 2024-12-31 | 0.13 |
Get Avalo Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("AVTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AVTX | $14.37 | -9.77% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 |